NEU neuren pharmaceuticals limited

intrepid2566, page-8

  1. 11,715 Posts.
    lightbulb Created with Sketch. 1543
    No problem Wayne. Thanks for your post.

    You wrote;

    The outline of initial findings by Dr Mondello relates to the first cohort of the Phase II Intrepid2566 trial. Enrolment for the first cohort, however, was completed in May 2011. Its fascinating why the findings are being presented at this stage. Would it really take more than two years to analyse the data?

    Perhaps it's been a work in progress?? Do you think it may also have something to do with evaluating the drug's possible molecular mechanisms? Note re outline, the markers are also being evaluated to identify possible molecular mechanisms of the drug. I found this fascinating.

    Also have another read of the Arrowhead presentation...

    http://www.neurenpharma.com/ssl/cms/files_cms/Arrowhead%20TBI%20Conference%20NNZ2566%20Presentation.pdf

    Tony












 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.63
Change
0.450(3.17%)
Mkt cap ! $1.823B
Open High Low Value Volume
$14.36 $14.75 $14.36 $8.589M 588.7K

Buyers (Bids)

No. Vol. Price($)
19 1098 $14.61
 

Sellers (Offers)

Price($) Vol. No.
$14.63 105 4
View Market Depth
Last trade - 15.38pm 10/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.